痛風治療薬の世界市場2021-2027:薬剤分類別(抗高尿酸血症薬、非ステロイド性抗炎症薬、コルチコステロイド、コルヒチン、その他)、用途別、地域別

【英語タイトル】Global Gout Therapeutics Market is Segmented by Drug class type (Antihyperuricemic Agents, Non-steroidal Anti-inflammatory Drugs, Corticosteroids, Colchicine, Other Drug Classes); by Application type (Acute Gout and Chronic Gout), Regional Forecasts 2021-2027

Bizwit Research & Consultingが出版した調査資料(BZW21OC308)・商品コード:BZW21OC308
・発行会社(調査会社):Bizwit Research & Consulting
・発行日:2021年9月15日
・ページ数:約200
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:米国、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥732,600見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥925,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Bizwit Research社は、2020年におよそXX億ドルであった痛風治療薬の世界市場規模が、2021年から2027年の間に15.5%以上の健全な成長率で成長すると予測しています。本調査資料では、世界の痛風治療薬市場について調査し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、薬剤分類別(抗高尿酸血症薬、非ステロイド性抗炎症薬、コルチコステロイド、コルヒチン、その他)分析、用途別(急性痛風、慢性痛風)分析、地域別分析、競争状況、調査プロセスなどの項目を掲載しております。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・痛風治療薬の世界市場規模:薬剤分類別(抗高尿酸血症薬、非ステロイド性抗炎症薬、コルチコステロイド、コルヒチン、その他)
・痛風治療薬の世界市場規模:用途別(急性痛風、慢性痛風)
・痛風治療薬の世界市場規模:地域別
・競争状況
・調査プロセス

Global Gout Therapeutics Market is valued approximately at USD XX billion in 2020 and is projected to grow with a healthy growth rate of more than 15.5% over the forecast period 2021-2028. Gout is a regular form of inflammatory arthritis that is very painful in long term. It usually affects one joint at a time. Many of times the symptoms get worse, called flares, and sometimes, there are no symptoms, known as remission. Though, there is no cure for gout, but you can effectively treat and manage the condition with a change in lifestyles, medication, and self-management strategies. The risk of gout increases when alcohol intake goes up. The key driving factors contributing to growth of Gout Therapeutics Market are growing adoption of biologics, increasing R&D on regenerative drugs for treatment and rising prevalence of gout with increasing alcohol consumption. For instance, as per the Australian Bureau of Statistics and National Health Survey 2017-2018, It has been estimated that 0.8% of total population) suffer from gout condition. It has been also found that Gout is more common in males than females, 9 out of 10 people suffered with gout are males. Hence, considering above all factors the market is expected to show growth in the near future. It has been seen that increasing occurrence of gout across the world is due to change in lifestyles patterns are likely to boost the market in the upcoming years. Increasing alcohol consumption, high purine diet, rising patient pool, rising obesity & kidney diseases among people, and rising consumption of certain medications such as diuretics could further increase the incidence of gout. Despite this, there are potential side-effects of most existing gout therapeutic drugs and high indirect cost for gout therapeutics. Hence, these factors could hamper the growth of the market in the long run.

Asia Pacific region is expanding its presence and is expected to observe the fastest growth over the forecasted period due to continuous increasing patients, rising adoption of gout therapies, rising investment by major operating players in this region. Furthermore, the increasing alcohol consumption & smoking habits and stressed lifestyles are likely to boost the gout therapeutics market during the forecast period.

Major market player included in this report are
Lannett Company, Inc
Boehringer Ingelheim
GlaxoSmithKline PLC
Horizon Therapeutics plc
Mylan NV
Novartis International AG
Regeneron Pharmaceuticals
Romeg Therapeutics, LLC.
Takeda Pharmaceutical Company Ltd
Teijin Pharma Ltd

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug class type:
Antihyperuricemic Agent
Non-steroidal Anti-inflammatory Drugs
Corticosteroids
Colchicine
Other Drug Classes

By Application type:
Acute Gout
Chronic Gout

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.

Target Audience of the Global Maple Water Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

❖ レポートの目次 ❖

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Gout Therapeutic Market, by region, 2019-2027 (USD Billion)
1.2.2. Gout Therapeutic Market, by Drug Class type, 2019-2027 (USD Billion)
1.2.3. Gout Therapeutic Market, by Application type, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Gout Therapeutic Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Gout Therapeutic Market Dynamics
3.1. Gout Therapeutic Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Growing Adoption of Biologics and Increasing R&D
3.1.1.2. Rising Prevalence of Gout with Increasing Alcohol Consumption
3.1.2. Market Restraint
3.1.2.1. Changing lifestyles and high purine diet
3.1.2.2. Rising patient pool
3.1.3. Market Opportunities
3.1.3.1. Potential side-effects of most existing gout therapeutic drugs
3.1.3.2. high indirect costs for therapy
Chapter 4. Global Gout Therapeutic Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Gout Therapeutic Market, by Drug Class type
5.1. Market Snapshot
5.2. Global Gout Therapeutic Market by Drug Class type, Performance – Potential Analysis
5.3. Global Gout Therapeutic Market Estimates & Forecasts by Drug Class type 2018-2027 (USD Billion)
5.4. Gout Therapeutic Market, Sub Segment Analysis
5.4.1. Antihyperuricemic Agents
5.4.2. Non-steroidal Anti-inflammatory Drugs
5.4.3. Corticosteroids
5.4.4. Colchicine
5.4.5. Other Drug Classes
Chapter 6. Global Gout Therapeutic Market, by Application type
6.1. Market Snapshot
6.2. Global Gout Therapeutic Market by Application type, Performance – Potential Analysis
6.3. Global Gout Therapeutic Market Estimates & Forecasts by Application type 2018-2027 (USD Billion)
6.4. Gout Therapeutic Market, Sub Segment Analysis
6.4.1. Acute Gout
6.4.2. Chronic Gout
Chapter 7. Global Gout Therapeutic Market, Regional Analysis
7.1. Gout Therapeutic Market, Regional Market Snapshot
7.2. North America Gout Therapeutic Market
7.2.1. U.S. Gout Therapeutic Market
7.2.1.1. Drug Class breakdown estimates & forecasts, 2018-2027
7.2.1.2. Application type breakdown estimates & forecasts, 2018-2027
7.2.2. Canada Gout Therapeutic Market
7.3. Europe Gout Therapeutic Market Snapshot
7.3.1. U.K. Gout Therapeutic Market
7.3.2. Germany Gout Therapeutic Market
7.3.3. France Gout Therapeutic Market
7.3.4. Spain Gout Therapeutic Market
7.3.5. Italy Gout Therapeutic Market
7.3.6. Rest of Europe Gout Therapeutic Market
7.4. Asia-Pacific Gout Therapeutic Market Snapshot
7.4.1. China Gout Therapeutic Market
7.4.2. India Gout Therapeutic Market
7.4.3. Japan Gout Therapeutic Market
7.4.4. Australia Gout Therapeutic Market
7.4.5. South Korea Gout Therapeutic Market
7.4.6. Rest of Asia Pacific Gout Therapeutic Market
7.5. Latin America Gout Therapeutic Market Snapshot
7.5.1. Brazil Gout Therapeutic Market
7.5.2. Mexico Gout Therapeutic Market
7.6. Rest of The World Gout Therapeutic Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Lannett Company, Inc
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Boehringer Ingelheim
8.2.3. GlaxoSmithKline PLC
8.2.4. Horizon Therapeutic Plc
8.2.5. Mylan NV
8.2.6. Novartis International AG
8.2.7. Regeneron Therapeutical
8.2.8. Takeda Pharmaceutical company Ltd
8.2.9. Teijin Pharma Ltd.
8.2.10. Romeg Therapeutics, LLC.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

List of Tables
TABLE 1. Global Gout Therapeutic Market, report scope
TABLE 2. Global Gout Therapeutic Market estimates & forecasts by region 2018-2027 (USD Billion)
TABLE 3. Global Gout Therapeutic Market estimates & forecasts by Drug Class type 2018-2027 (USD Billion)
TABLE 4. Global Gout Therapeutic Market estimates & forecasts by Application type 2018-2027 (USD Billion)
TABLE 5. Global Gout Therapeutic Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 6. Global Gout Therapeutic Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 7. Global Gout Therapeutic Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Gout Therapeutic Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Gout Therapeutic Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Gout Therapeutic Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Gout Therapeutic Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Gout Therapeutic Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Gout Therapeutic Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Gout Therapeutic Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Gout Therapeutic Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. Global Gout Therapeutic Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. Global Gout Therapeutic Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 18. Global Gout Therapeutic Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 19. Global Gout Therapeutic Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Global Gout Therapeutic Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 21. U.S. Gout Therapeutic Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 22. U.S. Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 23. U.S. Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 24. Canada Gout Therapeutic Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 25. Canada Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 26. Canada Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 27. UK Gout Therapeutic Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 28. UK Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 29. UK Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 30. Germany Gout Therapeutic Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 31. Germany Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 32. Germany Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 33. France Gout Therapeutic Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 34. France Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 35. France Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 36. Spain Gout Therapeutic Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 37. Spain Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 38. Spain Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 39. Italy Gout Therapeutic Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 40. Italy Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 41. Italy Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 42. ROE Gout Therapeutic Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 43. ROE Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 44. ROE Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 45. China Gout Therapeutic Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 46. China Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 47. China Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 48. India Gout Therapeutic Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 49. India Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 50. India Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 51. Japan Gout Therapeutic Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 52. Japan Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 53. Japan Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 54. Australia Gout Therapeutic Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 55. Australia Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 56. Australia Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 57. South Korea Gout Therapeutic Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 58. South Korea Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 59. South KoreaGout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 60. ROPAC Gout Therapeutic Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 61. ROPAC Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 62. ROPAC Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 63. Brazil Gout Therapeutic Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 64. Brazil Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 65. Brazil Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 66. Mexico Gout Therapeutic Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 67. Mexico Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 68. Mexico Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 69. ROLA Gout Therapeutic Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 70. ROLA Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 71. ROLA Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 72. ROW Gout Therapeutic Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 73. ROW Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 74. ROW Gout Therapeutic Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 75. List of secondary sources used in the study of Global Gout Therapeutic Market.
TABLE 76. List of primary sources used in the study of Global Gout Therapeutic Market.
TABLE 77. Years considered for the study.
TABLE 78. Exchange rates considered.

List of figures
FIG 1. Global Gout Therapeutic Market, research methodology
FIG 2. Global Gout Therapeutic Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Gout Therapeutic Market, key trends 2020
FIG 5. Global Gout Therapeutic Market, growth prospects 2021-2027
FIG 6. Global Gout Therapeutic Market, porters 5 force model
FIG 7. Global Gout Therapeutic Market, pest analysis
FIG 8. Global Gout Therapeutic Market, value chain analysis
FIG 9. Global Gout Therapeutic Market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Gout Therapeutic Market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Gout Therapeutic Market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Gout Therapeutic Market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Gout Therapeutic Market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Gout Therapeutic Market by segment, 2018 & 2027 (USD Billion)
FIG 15. Global Gout Therapeutic Market by segment, 2018 & 2027 (USD Billion)
FIG 16. Global Gout Therapeutic Market by segment, 2018 & 2027 (USD Billion)
FIG 17. Global Gout Therapeutic Market, regional snapshot 2018 & 2027
FIG 18. North America Gout Therapeutic Market 2018 & 2027 (USD Billion)
FIG 19. Europe Gout Therapeutic Market 2018 & 2027 (USD Billion)
FIG 20. Asia-Pacific Gout Therapeutic Market 2018 & 2027 (USD Billion)
FIG 21. Latin America Gout Therapeutic Market 2018 & 2027 (USD Billion)
FIG 22. Global Gout Therapeutic Market, company market share analysis (2020)

★調査レポート[痛風治療薬の世界市場2021-2027:薬剤分類別(抗高尿酸血症薬、非ステロイド性抗炎症薬、コルチコステロイド、コルヒチン、その他)、用途別、地域別] (コード:BZW21OC308)販売に関する免責事項を必ずご確認ください。
★調査レポート[痛風治療薬の世界市場2021-2027:薬剤分類別(抗高尿酸血症薬、非ステロイド性抗炎症薬、コルチコステロイド、コルヒチン、その他)、用途別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆